AstraZeneca
AZN
#51
Rank
NZ$480.79 B
Marketcap
NZ$310.14
Share price
2.18%
Change (1 day)
28.70%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2025 (TTM): NZ$10.22

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is NZ$9.93. In 2024 the company made an earnings per share (EPS) of NZ$7.60 an increase over its 2023 EPS that were of NZ$6.43.

EPS history for AstraZeneca from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$10.2234.41%
2024NZ$7.6018.23%
2023NZ$6.4381.13%
2022NZ$3.55631.03%
2021NZ$0.49-88.11%
2020NZ$4.09136.89%
2019NZ$1.72-39.41%
2018NZ$2.85-28.27%
2017NZ$3.97-14.37%
2016NZ$4.6324.11%
2015NZ$3.73127.55%
2014NZ$1.64-51.96%
2013NZ$3.42-58.95%
2012NZ$8.32-32.2%
2011NZ$12.27

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$18.65 87.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.06 21.42%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.28-77.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.28-36.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$38.56 288.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.46-65.17%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$14.79 48.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.24 23.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$5.79-41.65%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.31-36.46%๐Ÿ‡ฌ๐Ÿ‡ง UK